211 related articles for article (PubMed ID: 23307349)
21. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
22. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
23. Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle.
Iranpur Mobarakeh V; Modarressi MH; Rahimi P; Bolhassani A; Arefian E; Atyabi F; Vahabpour R
Int J Biol Macromol; 2019 May; 129():305-315. PubMed ID: 30738164
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid.
Chen CJ; Zhao ZX; Wang JC; Zhao EY; Gao LY; Zhou SF; Liu XY; Lu WL; Zhang Q
Int J Nanomedicine; 2012; 7():3837-49. PubMed ID: 22888238
[TBL] [Abstract][Full Text] [Related]
25. A nanoformulation of siRNA and its role in cancer therapy: in vitro and in vivo evaluation.
Jagani H; Rao JV; Palanimuthu VR; Hariharapura RC; Gang S
Cell Mol Biol Lett; 2013 Mar; 18(1):120-36. PubMed ID: 23271435
[TBL] [Abstract][Full Text] [Related]
26. Enhanced stability and knockdown efficiency of poly(ethylene glycol)-b-polyphosphoramidate/siRNA micellar nanoparticles by co-condensation with sodium triphosphate.
Nakanishi M; Patil R; Ren Y; Shyam R; Wong P; Mao HQ
Pharm Res; 2011 Jul; 28(7):1723-1732. PubMed ID: 21387148
[TBL] [Abstract][Full Text] [Related]
27. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery.
Almalik A; Day PJ; Tirelli N
Macromol Biosci; 2013 Dec; 13(12):1671-80. PubMed ID: 24106105
[TBL] [Abstract][Full Text] [Related]
28. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
Lee SJ; Huh MS; Lee SY; Min S; Lee S; Koo H; Chu JU; Lee KE; Jeon H; Choi Y; Choi K; Byun Y; Jeong SY; Park K; Kim K; Kwon IC
Angew Chem Int Ed Engl; 2012 Jul; 51(29):7203-7. PubMed ID: 22696263
[TBL] [Abstract][Full Text] [Related]
29. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
30. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
Cheng W; Tang C; Yin C
J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
[TBL] [Abstract][Full Text] [Related]
31. Development of chitosan nanoparticles as drug delivery system for a prototype capsid inhibitor.
Xue M; Hu S; Lu Y; Zhang Y; Jiang X; An S; Guo Y; Zhou X; Hou H; Jiang C
Int J Pharm; 2015 Nov; 495(2):771-82. PubMed ID: 26428629
[TBL] [Abstract][Full Text] [Related]
32. Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
Varkouhi AK; Verheul RJ; Schiffelers RM; Lammers T; Storm G; Hennink WE
Bioconjug Chem; 2010 Dec; 21(12):2339-46. PubMed ID: 21049986
[TBL] [Abstract][Full Text] [Related]
33. Efficient inhibition of uveal melanoma via ternary siRNA complexes.
Xie L; Yang Y; Shen J
Int J Pharm; 2020 Jan; 573():118894. PubMed ID: 31765784
[TBL] [Abstract][Full Text] [Related]
34. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
35. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
[TBL] [Abstract][Full Text] [Related]
36. Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats.
Shailender J; Ravi PR; Reddy Sirukuri M; Dalvi A; Keerthi Priya O
Drug Dev Ind Pharm; 2018 Jul; 44(7):1109-1119. PubMed ID: 29409342
[TBL] [Abstract][Full Text] [Related]
37. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
39. Comparison of polymeric siRNA nanocarriers in a murine LPS-activated macrophage cell line: gene silencing, toxicity and off-target gene expression.
Jensen LB; Griger J; Naeye B; Varkouhi AK; Raemdonck K; Schiffelers R; Lammers T; Storm G; de Smedt SC; Sproat BS; Nielsen HM; Foged C
Pharm Res; 2012 Mar; 29(3):669-82. PubMed ID: 21971827
[TBL] [Abstract][Full Text] [Related]
40. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
